Filing Details
- Accession Number:
- 0001209191-15-083599
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-04 17:18:26
- Reporting Period:
- 2015-12-03
- Filing Date:
- 2015-12-04
- Accepted Time:
- 2015-12-04 17:18:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1534287 | Bioamber Inc. | BIOA | Industrial Organic Chemicals (2860) | 980601045 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1575781 | A. Michael Hartmann | C/O Bioamber Inc. 1250 Rene Levesque West, Suite 4310 Montreal A8 H3B4W8 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-03 | 121,800 | $1.43 | 144,620 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2015-12-03 | 21,477 | $8.11 | 123,143 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Warrants (right to buy) | Disposition | 2015-12-03 | 121,800 | $0.00 | 121,800 | $1.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-02-06 | 2019-02-06 | No | 4 | X | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,000 | Indirect | Registered Plan account |
Footnotes
- The reporting person exercised a warrant to purchase 121,800 shares of BioAmber Inc. common stock for $1.43 a share. The reporting person paid the exercise price on a cashless basis, resulting in BioAmber Inc. withholding of 21,477 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 100,323 shares.
Billionaire Hedge Funds
